Medical Imaging Industry Statistics and Forecasts

This article was written by our expert who is surveying the industry and constantly updating the business plan for a radiologist.

Who wrote this content?

The Dojo Business Team

A team of financial experts, consultants, and writers

We're a team of finance experts, consultants, market analysts, and specialized writers dedicated to helping new entrepreneurs launch their businesses. We help you avoid costly mistakes by providing detailed business plans, accurate market studies, and reliable financial forecasts to maximize your chances of success from day one—especially in the radiology market.

What is the global market size now (revenue, units, geography)?

The global medical imaging market in 2025 is about USD 43.9–46 billion and is led by North America in revenue share.

Annual volumes are highest in X-ray and ultrasound, while MRI sells roughly 5,000 new scanners per year globally and CT placements remain strong. Regions rank roughly North America first (~38%), then Europe (~USD 12.9B) and Asia–Pacific (~USD 10.5B), with Latin America and Middle East/Africa smaller but rising.

For a radiology practice, these figures signal steady demand for core modalities (X-ray, ultrasound, CT) and room for selective premium growth in MRI and PET where reimbursement supports it.

APAC growth and density gains suggest future referral flows and teleradiology opportunities for cross-border reads.

You’ll find detailed market insights in our radiologist business plan, updated every quarter.

What growth rates are expected over the next 5–10 years (global and regional)?

The market is projected to grow at ~4.95–5.7% CAGR, reaching roughly USD 68–76 billion by 2032–2034.

Asia–Pacific is expected to outpace the global average on hospital build-outs, aging demographics, and expanding insurance coverage, while North America and Europe grow steadily through replacement cycles and outpatient shifts. Latin America and Middle East/Africa accelerate from a lower base as infrastructure scales.

For a radiology business, these growth rates justify multi-year capex plans with clear throughput targets per modality.

Build 5–10-year depreciation and cash flow models that match these regional demand curves.

Which modalities dominate today and how will shares change?

X-ray, CT, and ultrasound dominate installed base and unit shipments, while MRI holds a substantial revenue share and PET/SPECT remains smaller but strategic.

Digital X-ray upgrades, premium CT features (spectral/AI), high-channel MRI, and point-of-care ultrasound will sustain leadership. PET/CT and emerging PET/MRI will rise in oncology networks and academic centers, increasing case-mix complexity for radiologists.

Expect ultrasound’s role to expand in outpatient and community diagnostics and MRI to deepen in neuro, MSK, and body oncologic imaging.

Plan portfolio breadth: baseline (DR X-ray, 64-slice CT, cart ultrasound) plus one premium anchor (3T MRI or PET/CT) where payor mix warrants.

What are the fastest-growing modalities and why?

Ultrasound (especially portable/POCUS), advanced MRI, and hybrid PET/CT are among the fastest-growing segments.

Drivers include expanded indications (cardiac, MSK, oncology), AI-assisted protocols, and lower total cost of ownership for portable ultrasound in outpatient settings. PET growth tracks oncology pathways and theranostics, while MRI growth reflects high-value neuro and oncologic workups.

For a radiology practice, these trends support adding POCUS carts, upgrading MRI gradients/coils, and partnering for radiopharmaceutical supply in PET programs.

Sequence optimization and AI reconstruction can unlock higher throughput without compromising quality.

This is one of the strategies explained in our radiologist business plan.

Which regions are growing fastest and why?

Asia–Pacific is growing fastest, with China, India, and Japan driving large-scale adoption.

Contributors include hospital construction, insurance expansion, aging populations, and government investment; Saudi/GCC and Brazil also show strong project pipelines. Developed markets (US, Japan, South Korea, Western Europe) maintain high density and utilization, supporting replacements and advanced upgrades.

For radiologists, regional acceleration increases teleradiology demand, subspecialty reads, and second-opinion services.

Align referral networks and cloud PACS connectivity to capture cross-site volumes.

What are the top growth drivers in medical imaging?

• Aging demographics and rising incidence of cancer, cardiovascular, metabolic, and neurodegenerative diseases that increase imaging per capita.
• Technological advances: AI-assisted reconstruction/triage, spectral CT, high-channel MRI, portable ultrasound, and hybrid PET/CT or PET/MRI.
• Infrastructure expansion in emerging markets, with public-private partnerships and broader insurance coverage.
• Shift to outpatient imaging and value-based care pushing earlier, cost-effective diagnostics.
• Cloud PACS/VNA, interoperability, and remote reading models that scale radiologist productivity.

What barriers could slow industry growth?

• High capital and service costs for MRI, CT, and PET, plus siting/shielding and helium constraints.
• Regulatory timelines and evidence requirements that delay device approvals and AI clearances.
• Reimbursement pressure and prior-auth hurdles that reduce utilization or delay studies.
• Workforce shortages in radiology and technologists; training and maintenance gaps in emerging markets.
• Data governance, cybersecurity, and integration issues for AI/Cloud deployments.

We cover this exact topic in the radiologist business plan.

Who are the largest manufacturers and how do shares compare?

GE HealthCare, Siemens Healthineers, Philips, Canon Medical, and Fujifilm are the leading vendors across modalities.

GE and Siemens generally lead global share across multiple categories, with Philips, Canon, and Fujifilm strong in key modalities and regions; niche leaders exist in ultrasound and nuclear medicine subsegments. Competitive differentiation centers on AI software stacks, detector and gradient performance, dose management, and service networks.

For a radiologist-owned practice, vendor choice should weigh uptime guarantees, coil/probe ecosystem, and financing terms over headline price.

Bundle service contracts and training to protect throughput and image quality.

How are AI and ML used in imaging, and what is the impact?

The AI medical imaging market is ~USD 2B in 2025 and growing at a strong double-digit CAGR.

Radiology practices use AI for protocoling, reconstruction, triage, detection/quantification (e.g., lung nodules, LVO, PE), structured reporting, and workload balancing, which reduces turnaround time and variability. Measured benefits include faster reading times, earlier detection, and fewer repeat scans via AI-assisted acquisition.

Integrating AI within PACS/RIS and modality consoles yields the largest efficiency gains and cost offsets.

Track algorithm performance with QA dashboards and align with payors on use cases tied to measurable outcomes.

Get expert guidance and actionable steps inside our radiologist business plan.

What regulatory and reimbursement trends matter most?

• US/EU/Japan are tightening evidence and post-market surveillance for devices and AI/ML, affecting timelines and validation costs.
• Reimbursement is shifting toward value, preventive care, and outpatient settings, favoring lower cost per diagnosis and efficient pathways.
• Oncology and cardiology imaging often receive more favorable coverage, supporting PET/CT and advanced MRI indications.
• Prior authorization and documentation requirements remain significant gatekeepers for high-end modalities.
• Data protection and cybersecurity rules mandate robust cloud and AI governance in radiology practices.

Where will demand be strongest: hospitals vs. outpatient centers and telehealth?

Hospitals retain the largest demand for advanced modalities like MRI and PET/CT, while outpatient imaging centers dominate volume in X-ray, ultrasound, and CT.

Radiology clinics are expanding portable and point-of-care ultrasound for quick diagnostics, with cloud PACS enabling remote reads and tele-ultrasound workflows. Telehealth is catalyzing remote triage and AI-supported image review, especially for follow-up and chronic disease monitoring.

For a radiologist, the near-term mix skews to outpatient volume with selective hospital partnerships for complex cases.

Design scheduling and scanner hours to capture peak outpatient demand and hospital overflow agreements.

What are the investment trends in R&D and infrastructure?

Vendors are investing heavily in AI stacks, spectral CT, low-helium/helium-free MRI magnets, and hybrid PET technologies.

Public-private partnerships and health-system expansions in emerging markets drive equipment tenders, while venture investment flows into cloud viewers, AI quantification, and portable devices. Capital shifts toward digital upgrades and capacity expansion that raise radiologist productivity per hour.

For practices, the best ROI often comes from software (AI, scheduling, reporting) paired with protocol optimization and targeted hardware refreshes.

Sequence, coil, and detector upgrades can lift throughput and reimbursement-eligible indications without full system replacement.

This is one of the many elements we break down in the radiologist business plan.

Conclusion

This article is for informational purposes only and should not be considered financial advice. Readers are encouraged to consult with a qualified professional before making any investment decisions. We accept no liability for any actions taken based on the information provided.

Sources

1. Global Market Insights – Medical Imaging Market
2. Grand View Research – Medical Imaging Systems Market
3. Global Electronics Council – Imaging Equipment Sustainability Report
4. Meticulous Research – Medical Imaging Market
5. Collective Minds – MRI Utilization Overview
6. Fortune Business Insights – Imaging Equipment Market
7. Data Bridge Market Research – Global Medical Imaging
8. Custom Market Insights – Imaging Reagents
9. Cognitive Market Research – AI in Medical Imaging
10. Statista – Imaging Analytics Software Market